- 首页
- ECHA 常见问答
- 详请
NMP 的用户如何确保他们遵守限制条款 71 中规定的强制性衍生无效应水平 (DNEL)?
问题(中文)
NMP 的用户如何确保他们遵守限制条款 71 中规定的强制性衍生无效应水平 (DNEL)?
Question (EN)
How can users of NMP ensure that they comply with the mandatory derived no-effect level (DNELs) established in the restriction Entry 71?
中文内容由 Google Cloud Translation 自动生成,仅供参考;请以英文原文为准。问答资料来自欧盟化学品管理局(ECHA)官方网站。
答案(中文)
本指南阐明了 NMP 的用户如何确保其遵守 REACH 法规 (EU) No 1907/2006 附件 XVII 第 71 条中对 1-甲基-2-吡咯烷酮 (NMP) 的限制中规定的衍生无效应水平 (DNEL)。该指南解释了当除了职业接触限值 (OEL) 之外还有强制性 DNEL 时该如何进行。它阐明了用户需要做什么来充分控制风险。几个良好实践的例子说明了一些公司在转移、维护和取样等各种任务中控制吸入和皮肤暴露的设备类型。此外,还描述了监测方法的示例,包括生物监测方法。该文件是与行业利益相关者密切合作编写的,并得到了成员国当局的认可。您的语言:保加利亚语捷克语丹麦语德语希腊语英语西班牙语爱沙尼亚语芬兰语法语克罗地亚语匈牙利语意大利语立陶宛语拉脱维亚语马耳他语荷兰语波兰语葡萄牙语罗马尼亚语斯洛伐克语斯洛文尼亚语瑞典语
Answer (EN)
This guideline clarifies how users of NMP can ensure their compliance with the derived no-effect levels (DNELs) established in the restriction on 1-methyl-2-pyrrolidone (NMP) in entry 71 of Annex XVII to the REACH Regulation (EU) No 1907/2006. The guideline explains how to proceed when there are mandatory DNELs in addition to the occupational exposure limit values (OELs). It clarifies what the user needs to do to adequately control the risks. Several examples of good practice illustrate the type of equipment some companies have in place to control inhalation and dermal exposure in various tasks such as transfers, maintenance and sampling. In addition, examples of monitoring methods, including biological monitoring methods, are described. The document has been prepared in close cooperation with the industry stakeholders and endorsed by the Member States authorities.In your language:BulgarianCzechDanishGermanGreekEnglishSpanishEstonianFinnishFrenchCroatianHungarianItalianLithuanianLatvianMalteseDutchPolishPortugueseRomanianSlovakSlovenianSwedish